nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.119	0.119	CcSEcCtD
Gadodiamide—Encephalopathy—Hydrochlorothiazide—nephrolithiasis	0.0499	0.0499	CcSEcCtD
Gadodiamide—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0408	0.0408	CcSEcCtD
Gadodiamide—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0326	0.0326	CcSEcCtD
Gadodiamide—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.0248	0.0248	CcSEcCtD
Gadodiamide—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.0246	0.0246	CcSEcCtD
Gadodiamide—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.0245	0.0245	CcSEcCtD
Gadodiamide—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0244	0.0244	CcSEcCtD
Gadodiamide—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.0233	0.0233	CcSEcCtD
Gadodiamide—Migraine—Hydrochlorothiazide—nephrolithiasis	0.0229	0.0229	CcSEcCtD
Gadodiamide—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0218	CcSEcCtD
Gadodiamide—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0218	0.0218	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0177	0.0177	CcSEcCtD
Gadodiamide—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0176	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0176	CcSEcCtD
Gadodiamide—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0176	0.0176	CcSEcCtD
Gadodiamide—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.0161	0.0161	CcSEcCtD
Gadodiamide—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.016	0.016	CcSEcCtD
Gadodiamide—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.0155	0.0155	CcSEcCtD
Gadodiamide—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.015	0.015	CcSEcCtD
Gadodiamide—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0149	CcSEcCtD
Gadodiamide—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0144	CcSEcCtD
Gadodiamide—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0137	CcSEcCtD
Gadodiamide—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0131	CcSEcCtD
Gadodiamide—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.013	0.013	CcSEcCtD
Gadodiamide—Malaise—Hydrochlorothiazide—nephrolithiasis	0.0126	0.0126	CcSEcCtD
Gadodiamide—Syncope—Hydrochlorothiazide—nephrolithiasis	0.0125	0.0125	CcSEcCtD
Gadodiamide—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0123	CcSEcCtD
Gadodiamide—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Gadodiamide—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Gadodiamide—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Gadodiamide—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0119	0.0119	CcSEcCtD
Gadodiamide—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0118	CcSEcCtD
Gadodiamide—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.0117	0.0117	CcSEcCtD
Gadodiamide—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Gadodiamide—Oedema—Hydrochlorothiazide—nephrolithiasis	0.0114	0.0114	CcSEcCtD
Gadodiamide—Shock—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0112	CcSEcCtD
Gadodiamide—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0111	CcSEcCtD
Gadodiamide—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.011	0.011	CcSEcCtD
Gadodiamide—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0107	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0104	CcSEcCtD
Gadodiamide—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0103	CcSEcCtD
Gadodiamide—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Gadodiamide—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0102	CcSEcCtD
Gadodiamide—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0101	CcSEcCtD
Gadodiamide—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00985	0.00985	CcSEcCtD
Gadodiamide—Pain—Hydrochlorothiazide—nephrolithiasis	0.00977	0.00977	CcSEcCtD
Gadodiamide—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00941	0.00941	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00934	0.00934	CcSEcCtD
Gadodiamide—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00907	0.00907	CcSEcCtD
Gadodiamide—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00903	0.00903	CcSEcCtD
Gadodiamide—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00903	0.00903	CcSEcCtD
Gadodiamide—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00841	0.00841	CcSEcCtD
Gadodiamide—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00819	0.00819	CcSEcCtD
Gadodiamide—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00808	0.00808	CcSEcCtD
Gadodiamide—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00781	0.00781	CcSEcCtD
Gadodiamide—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00755	0.00755	CcSEcCtD
Gadodiamide—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00726	0.00726	CcSEcCtD
Gadodiamide—Rash—Hydrochlorothiazide—nephrolithiasis	0.0072	0.0072	CcSEcCtD
Gadodiamide—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00719	0.00719	CcSEcCtD
Gadodiamide—Headache—Hydrochlorothiazide—nephrolithiasis	0.00715	0.00715	CcSEcCtD
Gadodiamide—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00678	0.00678	CcSEcCtD
